Drinks

SABMiller Name to Disappear as Shareholders Vote on Megabrew

By Publications Checkout
SABMiller Name to Disappear as Shareholders Vote on Megabrew

SABMiller's name will disappear after its $104 billion takeover by Anheuser-Busch InBev, eliminating a corporate moniker whose roots date back to the late nineteenth century.

AB InBev will retain its name, the Budweiser maker said in a statement Wednesday, after its shareholders approved the beer industry’s biggest-ever acquisition at a meeting in Brussels. SABMiller shareholders are meeting separately Wednesday, in London, and most of them voting by proxy support the takeover, people familiar with the matter said Tuesday.

The bid requires assent from 75 per cent of SABMiller shareholders, and its two biggest investors are voting separately after a UK court ruling. If it’s approved, a deal that’s stretched over a year and required regulatory approval around the globe will conclude 10 October. SABMiller shares rose 0.2 percent to £44.72 in London, while AB InBev shares were suspended pending the outcome of the vote.

The vote concludes a process that saw the brewers haggle for weeks over price before spending months hammering out divestments to appease antitrust regulators. The structure of AB InBev’s bid caused division among SABMiller shareholders, leading to the court ruling.

Eliminating SABMiller’s name from the combined entity follows AB InBev’s decision to include just one SAB executive on its senior management team. The Belgian maker of Stella Artois and Beck’s is seeking $1.4 billion of annual savings from the takeover, equivalent to almost a tenth of SABMiller’s $15 billion in annual revenue. Part of the savings will come from cutting about 3 per cent of the enlarged workforce, or about 5,500 jobs.

A predecessor company of London-based SABMiller, maker of Castle Lager and Foster’s, started selling beer to gold miners in Johannesburg in 1895. It acquired America’s Miller Brewing in 2002.

News by Bloomberg, edited by Hospitality Ireland

ADVERTISEMENT